A Periodic Transaction Report filed with the U.S. House of Representatives shows Hon. Richard Dean Dr McCormick sold shares of Abbott Laboratories Common Stock (ABT) on 2026-07-30. The transaction, valued between $1,001 and $15,000, was made by the member of Congress personally and was held through a Growth Partners Roth IRA account.
The filing is disclosed under the STOCK Act, which requires members of Congress to report personal securities transactions within a set window after they occur. Our internal classification tags this filing as a congress sale, reflecting a straightforward disposal of ABT shares rather than a new position or an increase in holdings.
A Notable Cross-Signal at Abbott
What makes this filing worth watching is its timing relative to activity inside the company itself. Within 30 days of McCormick’s reported sale date, Abbott insider Morrone Louis H. also sold shares of ABT, in a transaction valued at $642,506, filed on 2026-08-11. Seeing both a congressional disclosure and a corporate insider sale of the same stock in close proximity is the kind of pattern whoisbuyingnow.com exists to surface. It does not establish coordination or any wrongdoing between the two filers, who are unrelated parties disclosing under entirely separate reporting regimes, but it does mean two distinct groups of ABT stakeholders reduced exposure to the stock within a short window of each other.
McCormick’s use of a Roth IRA structure for the trade is also worth noting for readers tracking how members of Congress commonly hold and trade equities. Retirement-account structures like this are a recurring feature in STOCK Act filings across both parties and are not unique to this transaction.
This is not the first time ABT has drawn attention from congressional trading disclosures. Our earlier coverage, Julia Letlow Buys Abbott Labs (ABT) Stock, Discloses 292 Days Late, detailed a purchase of the same stock by another House member, filed well outside the STOCK Act’s standard disclosure window. Taken together, the two filings show ABT appearing on both sides of the ledger in congressional trading activity over the past two years, with one member buying and another selling.
As always, a Periodic Transaction Report reflects a legally required disclosure, not an evaluation of the stock or any judgment on the member’s intent. Readers interested in broader institutional positioning around large-cap holdings like ABT can also review our quarterly tracking of asset managers, such as Manufacturers Life Insurance Company: 13F Moves Tracked Quarterly, for a fuller picture of who holds what and when positions shift.